A 2-item food security instrument captures similar mortality risk information as instruments with more items among adults in the US.

Topline data were announced from a phase 3 trial evaluating setmelanotide for the treatment of acquired hypothalamic obesity.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

HealthDay News — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions ...

Researchers have found that patients with stage B heart failure characteristics and type 2 diabetes have impaired functional capacity.

The table below is a review of notable updates that occurred in March 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

The researchers observed an increase in CeAD incidence from 10.7 to 45.6 cases per million population from 2005 to 2019, with an average annual percent change of 10.21%. HealthDay News — Cervical ...

The CDC has not only lost nearly a fifth of its workforce, it has also been directed to slash $2.9 billion in contract spending.

A study has found that hospitalization for COPD increases risk for ASCVD hospitalization among older adults with established ASCVD.

Decline in executive function was faster among college graduates compared with stroke survivors with less than a high school education.

Researchers determined patients with paroxysmal hemoglobinuria may benefit from receiving ravulizumab over the long term.

For patients with OHCA, a critical factor in determining survival and long-term outcomes is how quickly CPR is initiated.